SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cell Genesys (CEGE) -- Ignore unavailable to you. Want to Upgrade?


To: david james who wrote (791)3/18/2000 7:05:00 PM
From: sam  Respond to of 1298
 
For a different take on the CEGE problem, see: geneticcapital.com



To: david james who wrote (791)3/19/2000 12:27:00 AM
From: Jane4IceCream  Respond to of 1298
 
I happen to think CEGE moved up Friday due to the news release. If CEGE is strengthening we shall have a better indication of that come next week.

Jane



To: david james who wrote (791)3/19/2000 10:59:00 AM
From: SouthFloridaGuy  Respond to of 1298
 
Another possible reason for the drop is that CEGE was sold by individual investors who really didn't understand what they got into and just dumped the stock in heavy droves after the Clinton remarks.

Before that ugly day, CEGE was in a less pronounced correction. Uptrend still remains contact with the 50day Moving Average being held on Wednesday.



To: david james who wrote (791)3/20/2000 1:54:00 PM
From: Cheryl Galt  Read Replies (2) | Respond to of 1298
 
CEGE is on sale, right now. Mid 26's.
No news, no new sec filings. Just a buying opportunity.

Regards,
Cheryl